You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,314,904


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,314,904
Title:Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist
Abstract: The present invention provides methods for enhancing the efficacy and/or safety of a vaccine. In certain embodiments, the invention provides methods to increase or potentiate the immune response to a vaccine in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody in combination with said vaccine. In certain embodiments, the methods of the present invention are used to afford enhanced protection to an infectious disease such as whooping cough.
Inventor(s): Purcell; Lisa (Garnerville, NY), Graham; Neil (Croton-on-Hudson, NY), Murphy; Andrew J. (Croton-on-Hudson, NY), Evans; Robert (Cambridge, MA)
Assignee: Regeneron Pharmaceuticals, Inc. (Tarrytown, NY)
Application Number:15/436,032
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,314,904

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. The United States Patent and Trademark Office (USPTO) plays a crucial role in evaluating and granting these patents. This article will delve into a comprehensive and critical analysis of the claims and the patent landscape surrounding a specific patent, using the principles and regulations that govern patent law in the United States.

Understanding Patent Claims

Patent claims are the heart of a patent application, as they define the scope of the invention and the rights granted to the patentee. According to the USPTO, claims must "particularly point out and distinctly define the metes and bounds of the subject matter that will be protected by the patent grant"[4].

The Importance of Claim Drafting

Drafting patent claims is a meticulous process. Claims must meet the requirements of 35 U.S.C. §112, which includes enablement, written description, and best mode. The "definiteness" requirement under 35 U.S.C. §112(b) is particularly critical, as claims must be clear and distinct to avoid ambiguity[4].

Automated Systems for Patent Claims Analysis

Given the complexity and increasing volume of patent claims, automated systems have been developed to facilitate the examination process. For instance, the "Patent Claims Analysis System and Method" described in US20110138338A1 helps in importing, parsing, and arranging claims in a hierarchical order, making it easier for users to review and analyze the claims[2].

National Security and Patent Secrecy

In certain cases, patent applications may involve inventions that could be detrimental to national security if disclosed. The Department of Defense (DoD) has a specific process for reviewing such patent applications. Under DoD Directive 5535.02, the Heads of the DoD Components are responsible for determining if the disclosure of an invention might be detrimental to national security and for recommending the imposition of secrecy orders[1].

Patent Litigation and Non-Practicing Entities (NPEs)

The patent landscape is also influenced by litigation trends. Recent data indicates that US patent litigation has increased, with a notable rise in filings by Non-Practicing Entities (NPEs)[3]. This trend highlights the importance of robust patent claims that can withstand legal challenges.

The Role of the USPTO

The USPTO is central to the patent process, responsible for evaluating patent applications and ensuring they meet the statutory requirements. The USPTO's mission includes driving U.S. innovation and global competitiveness, and it must adapt to changing demand and economic conditions to fulfill this mission[5].

Critical Analysis of Patent 10,314,904

Claim Structure and Scope

To analyze the claims of a specific patent like 10,314,904, one must examine the claim structure and scope. This involves looking at the independent and dependent claims, how they are arranged, and whether they meet the definiteness and enablement requirements.

Prior Art and Novelty

The patent must also be evaluated against prior art to ensure it meets the novelty and non-obviousness requirements under 35 U.S.C. §102 and §103. This involves a thorough search of existing patents and publications to determine if the invention is truly new and innovative[4].

Litigation Risks

Given the increasing trend in patent litigation, it is crucial to assess the litigation risks associated with the patent. This includes analyzing the patent's vulnerability to challenges by NPEs or other entities and ensuring that the claims are robust enough to withstand such challenges[3].

National Security Implications

If the patent involves technology with potential national security implications, it must undergo the DoD's patent security review process. This ensures that the disclosure of the invention does not pose a risk to national security[1].

Key Takeaways

  • Clear and Distinct Claims: Patent claims must be clear, distinct, and meet the statutory requirements to ensure the invention is well-defined and protected.
  • Automated Analysis: Automated systems can significantly aid in the analysis and review of patent claims, especially in complex cases.
  • National Security: Inventions with national security implications must undergo a rigorous review process to ensure their disclosure does not harm national interests.
  • Litigation Preparedness: Patents must be drafted with litigation risks in mind, ensuring they can withstand challenges from NPEs and other entities.
  • USPTO Role: The USPTO plays a critical role in evaluating and granting patents, and its processes and policies are essential for maintaining the integrity of the patent system.

FAQs

Q: What are the key requirements for drafting patent claims? A: Patent claims must particularly point out and distinctly define the metes and bounds of the subject matter, meeting the requirements of 35 U.S.C. §112, including enablement, written description, and best mode[4].

Q: How does the DoD handle patent applications with national security implications? A: The DoD has a specific process for reviewing patent applications that might be detrimental to national security, involving the Heads of the DoD Components and the Director, Defense Technology Security Administration[1].

Q: What is the impact of automated systems on patent claims analysis? A: Automated systems help in importing, parsing, and arranging claims in a hierarchical order, reducing the amount of information users need to review and making the analysis process more efficient[2].

Q: Why is it important to consider litigation risks when drafting patent claims? A: Considering litigation risks ensures that the patent claims are robust enough to withstand challenges from NPEs and other entities, protecting the patentee's rights[3].

Q: What is the role of the USPTO in the patent process? A: The USPTO evaluates patent applications, ensures they meet statutory requirements, and grants patents, playing a central role in driving U.S. innovation and global competitiveness[5].

Sources

  1. Department of Defense - DIRECTIVE - Executive Services Directorate

    • "DoD Patent Security Review Process"
    • March 24, 2010, Incorporating Change 1, July 28, 2017[1].
  2. US20110138338A1 - Patent Claims Analysis System and Method

    • Google Patents[2].
  3. Q3 in Review: US NPE Upswing Continues as UPC Comes Further into Focus

    • RPX Corporation Blog Post
    • October 8, 2024[3].
  4. Drafting a Provisional Application - USPTO

    • USPTO
    • June 5, 2013[4].
  5. United States Patent and Trademark Office Fiscal Year 2024 Congressional Budget Submission

    • USPTO
    • March 31, 2023[5].

More… ↓

⤷  Subscribe

Details for Patent 10,314,904

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 March 28, 2017 10,314,904 2036-02-19
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 October 19, 2018 10,314,904 2036-02-19
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 June 18, 2020 10,314,904 2036-02-19
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 June 14, 2021 10,314,904 2036-02-19
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 October 20, 2021 10,314,904 2036-02-19
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.